CyGenics Appoints Chief Scientific Officer

Australian scientist Associate Professor Mark Kirkland to assume position

14-Dec-2005

CyGenics Ltd. announced the appointment of Associate Professor Mark Kirkland as its Chief Scientific Officer, with effect from 1st December 2005.

Associate Professor Kirkland is a specialist haematologist , with more than 25 years experience as a medical practitioner and over 30 years' experience in stem cell research. He received his initial training and PhD at Flinders Medical Centre in South Australia and undertook postdoctoral research at the Leukaemia Research Unit at Hammersmith Hospital, London. He has extensive experience in tissue banking, having worked with the Australian Red Cross Blood Service, with both public and private cord blood banks, and in the area of bone banking.

He was a member of the committee that developed the Australian (NPAAC) guidelines for haemopoietic stem cells. Associate Professor Kirkland has previously held both executive management and clinical positions at a number of institutions and organisations. He was previously the Chief of Service for Geelong Hospital Pathology Service, the Director of the Douglas Hocking Research Institute and a Director of PathCare Consulting Pathologists. He has also held the roles of Regional Transfusion Officer and Medical Director of Research for the Australian Red Cross Blood Service, and Director of Haematology and Blood Bank at Geelong Hospital Pathology Service.

Associate Professor Kirkland was the founder and CEO of BioCell Pty Ltd, the Australian cord blood bank in which CyGenics recently acquired a 51% equity stake. Associate Professor Kirkland carries out stem cell research at the Department of Clinical and Biomedical Sciences, University of Melbourne. His current research interests include stem cell expansion and reprogramming, with particular emphasis on developing novel approaches to the production of insulin-producing cells and cardiac cells from cord blood stem cells, for the treatment of diabetes and heart disease, respectively.

https://www.bionity.com/en/news/50853/cygenics-appoints-chief-scientific-officer.html